Bicycle Therapeutics Plc - ADR
BCYC
Market Cap$513.48M
Close$
$-2.25
130.8% downside
Current Fair Value
130.8% downsideOvervalued by 130.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $513.48 Million |
|---|---|
| Enterprise Value | $-264,358,526.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.29 |
| Beta | 1.47 |
| Outstanding Shares | 69,196,945 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.53 |
|---|---|
| PEG | -1.96 |
| Price to Sales | - |
| Price to Book Ratio | 0.73 |
| Enterprise Value to Revenue | -10.27 |
| Enterprise Value to EBIT | 1.14 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.06 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bicycle Therapeutics Plc
CEO: Kevin Lee